Seno Medical (United States)

Recent papers from Seno Medical (United States)

1. Artificial intelligence in musculoskeletal radiology: practical aspects and latest perspectivesBJR|Open · 2024
2. Reproductive Carrier Screening Results With Maternal Health Implications During PregnancyObstetrics and Gynecology · 2023
3. Ultrasound Imaging Using the Coherence of Estimated Channel DataIEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control · 2022
4. Opto-acoustic imaging of relative blood oxygen saturation and total hemoglobin for breast cancer diagnosisJournal of Biomedical Optics · 2019
5. Optoacoustic Imaging and Gray-Scale US Features of Breast Cancers: Correlation with Molecular SubtypesRadiology · 2019
6. Optoacoustic imaging of the breast: correlation with histopathology and histopathologic biomarkersEuropean Radiology · 2019
7. Clinical optoacoustic imaging combined with ultrasound for coregistered functional and anatomical mapping of breast tumorsPhotoacoustics · 2018
8. Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammographyClinicoEconomics and Outcomes Research · 2018
9. Development of humidity-responsive self-healing zwitterionic polyurethanes for renewable shape memory applicationsRSC Advances · 2017
10. Exact solution for a photoacoustic wave from a finite-length cylindrical sourceThe Journal of the Acoustical Society of America · 2015
11. A randomized, double-blind, multiple-dose study of the pan-genotypic NS5A inhibitor samatasvir in patients infected with hepatitis C virus genotype 1, 2, 3 or 4Journal of Hepatology · 2014
12. Pharmacokinetics, Pharmacodynamics, and Tolerability of GS-9851, a Nucleotide Analog Polymerase Inhibitor, following Multiple Ascending Doses in Patients with Chronic Hepatitis C InfectionAntimicrobial Agents and Chemotherapy · 2012
13. A Phase I, Randomized, Placebo-Controlled, 3-Day, Ascending-Dose Study of Gs-9451, An Ns3/4A Protease Inhibitor, in Genotype 1 Hepatitis C PatientsAntiviral Therapy · 2012
14. Single- and Multiple-Ascending-Dose Studies of the NS3 Protease Inhibitor Asunaprevir in Subjects with or without Chronic Hepatitis CAntimicrobial Agents and Chemotherapy · 2012
15. Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1New England Journal of Medicine · 2012
16. Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3Gut · 2011
17. Telaprevir for Retreatment of HCV InfectionNew England Journal of Medicine · 2011
18. Boceprevir for Previously Treated Chronic HCV Genotype 1 InfectionNew England Journal of Medicine · 2011
19. Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1Hepatology · 2010
20. Phase 1b Study of Pegylated Interferon Lambda 1 With or Without Ribavirin in Patients with Chronic Genotype 1 Hepatitis C Virus Infection†Hepatology · 2010